Skip to main content

AFATINIB

Tracking # 20-841183

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

AFATINIB, A TYROSINE KINASE INHIBITOR, IS A WIDELY USED MEDICATION FOR NON-SMALL CELL LUNG CARCINOMA. THIS ACTIVITY EDUCATES HEALTH CARE PROVIDERS ON THE INDICATIONS, MECHANISM OF ACTION, ADVERSE REACTIONS, AND TOXICITY. IT ALSO REVIEWS THE NECESSITY OF ENHANCING HEALTH CARE OUTCOMES BY NECESSITATING AN INTERPROFESSIONAL APPROACH TO THE MANAGEMENT OF THE DRUG.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I